Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades
Contact Dermatitis · 2024
DOI: 10.1111/cod.14552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contact Dermatitis, 2024. Verfasst von Sebastian Vigand Svendsen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Ophthalmic Solutions, Patch Tests. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The prevalence of contact allergy to various ophthalmic medications appears to be rare; however, data on culprits, clinical relevance of sensitizations, and changes in frequency within recent decades are limited.
Objective
This study aimed to investigate the clinical relevance, risk factors, and prevalence of contact allergy to topical ophthalmic medications in patients suspected of allergic contact dermatitis to ophthalmic medication.
Methods
We retrospectively analysed patch test results and clinical data for 754 patients patch‐tested with an ophthalmic medication series at our tertiary referral centre between January 1992 and December 2022.
Results
In total, 37.5% (283/754) of patch‐tested patients had a contact allergy to at least one ophthalmic allergen, with 87.3% (247) being clinically relevant sensitization. Phenylephrine (31.8%, 192/604), povidone‐iodine (29%, 27/93), and tobramycin (23%, 46/200) were the most important sensitizers. The incidence of contact allergies increased significantly in a linear manner ( p = 0.008) from 20% to 44.1% within the study period. Male sex and age above 40 were risk factors for contact allergy to ophthalmic medication.
Conclusions
One third of patch tested patients had allergic contact dermatitis to ophthalmic medication, particularly phenylephrine. Male sex and age above 40 years were independent risk factors and drove the linear increase in contact allergy to ophthalmic medications within the past 31 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Sebastian Vigand Svendsen, Charlotte G Mortz, Kristian Fredløv Mose
Zitieren
APA
Svendsen, S. V., Mortz, C. G., & Mose, K. F. (2024). Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades. Contact Dermatitis. https://doi.org/10.1111/cod.14552
Vancouver
Svendsen SV, Mortz CG, Mose KF. Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades. Contact Dermatitis. 2024. doi:10.1111/cod.14552
BibTeX
@article{Svendsen2024,
author = {Svendsen, Sebastian Vigand and Mortz, Charlotte G and Mose, Kristian Fredløv},
title = {Contact allergy to topical ophthalmic medications: A retrospective single‐centre study of three decades},
journal = {Contact Dermatitis},
year = {2024},
doi = {10.1111/cod.14552}
}
EUVIMED